Aisling Ann O’Kane

Seth Bullock, Nirav Ajmeri, Mike Batty et al.

Advances in artificial intelligence (AI) have great potential to help address societal challenges that are both collective in nature and present at national or trans-national scale. Pressing challenges in healthcare, finance, infrastructure and sustainability, for instance, might all be productively addressed by leveraging and amplifying AI for national-scale collective intelligence. The development and deployment of this kind of AI faces distinctive challenges, both technical and socio-technical. Here, a research strategy for mobilising inter-disciplinary research to address these challenges is detailed and some of the key issues that must be faced are outlined.

Sam Gordon James, Miranda Elaine Glynis Armstrong, Aisling Ann O'Kane et al.

Background: Type 1 diabetes (T1D) has seen a rapid evolution in management technology and forms a useful case study for the future management of other chronic conditions. Further development of this management technology requires an exploration of its real-world use and the potential of additional data streams. To facilitate this, we contribute the BrisT1D Dataset to the growing number of public T1D management datasets. The dataset was developed from a longitudinal study of 24 young adults in the UK who used a smartwatch alongside their usual T1D management. Findings: The BrisT1D dataset features both device data from the T1D management systems and smartwatches used by participants, as well as transcripts of monthly interviews and focus groups conducted during the study. The device data is provided in a processed state, for usability and more rapid analysis, and in a raw state, for in-depth exploration of novel insights captured in the study. Conclusions: This dataset has a range of potential applications. The quantitative elements can support blood glucose prediction, hypoglycaemia prediction, and closed-loop algorithm development. The qualitative elements enable the exploration of user experiences and opinions, as well as broader mixed-methods research into the role of smartwatches in T1D management.

Taku Yamagata, Aisling O'Kane, Amid Ayobi et al.

In this paper we investigate the use of model-based reinforcement learning to assist people with Type 1 Diabetes with insulin dose decisions. The proposed architecture consists of multiple Echo State Networks to predict blood glucose levels combined with Model Predictive Controller for planning. Echo State Network is a version of recurrent neural networks which allows us to learn long term dependencies in the input of time series data in an online manner. Additionally, we address the quantification of uncertainty for a more robust control. Here, we used ensembles of Echo State Networks to capture model (epistemic) uncertainty. We evaluated the approach with the FDA-approved UVa/Padova Type 1 Diabetes simulator and compared the results against baseline algorithms such as Basal-Bolus controller and Deep Q-learning. The results suggest that the model-based reinforcement learning algorithm can perform equally or better than the baseline algorithms for the majority of virtual Type 1 Diabetes person profiles tested.